
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Keywords: Aβ; amyloid beta; AD; Alzheimer's disease; Akt; protein kinase B; α-syn; α-synuclein; BAD; Bcl-2 antagonist of death; BBB; blood brain barrier; Bcl-2; B-cell lymphoma 2; Bcl-XL; B-cell lymphoma extra large; Bim; Bcl-2 interacting mediator of death; cAM